The Lexaria CanPharm Corp. is the exclusive worldwide provider of DehydratechTM drug delivery technology for the cannabis industry, licensed from our parent Lexaria Bioscience Corp.
DehydraTECHTM drug delivery technology is protected by over 50 patents granted or pending worldwide and is proven effective in multiple international studies in greatly assisting rapidity and quantity of absorption of lipophilic molecules.
Lexaria CanPharm is a Canadian company headquartered in the first G20 nation to have provided a federally legal framework for Cannabis and is one of the most advanced cannabinoid research companies in the world.
Lexaria’s patented technology, DehydraTECH delivers these important benefits for cannabis users:
Eliminates the strong tastes/odors of cannabis oils and by-products, without the need for unwanted sugar or sweeteners. Lower calorie, healthier edible products are the result.
Delivery into blood proven in as little as 2 minutes. Effects commonly felt within 15 min vs. 60-120 min. Tested via human clinical trials.
Initial testing indirectly evidences DehydraTECH may deliver ingested molecules through the lymphatic system instead of being subject to immediate liver exposure, potentially mitigating unwanted side effects and reducing liver biotransformation.
Bio-absorption increases by 2 – 10X, to equate or exceed that of other routes of administration like inhalational delivery. Lexaria’s tech is proven to deliver more cannabinoids to your bloodstream.